Frank G. Ondrey
Works at
Associate professor
Sources: reporter.nih.gov
Grants and prizes
R01, Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia, R01CA254270, 2022–2027, Sep 4, 2025
Sources: reporter.nih.gov
Associate professor
Sources: reporter.nih.gov
R01, Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia, R01CA254270, 2022–2027, Sep 4, 2025
Sources: reporter.nih.gov